Exome Asset Management »

Neumora Therapeutics shares owned by Exome Asset Management

Quarter-by-quarter ownership of Neumora Therapeutics shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $207k 600 345.00

More positions owned by Exome Asset Management

Ionis Pharmaceuticals (IONS)
Cytokinetics Com New (CYTK)
Bridgebio Pharma (BBIO)
Cogent Biosciences (COGT)
Guardant Health (GH)
Eli Lilly & Co. (LLY)
I Mab Sponsored Ads (IMAB)
Praxis Precision Medicines I Com New (PRAX)
Vera Therapeutics Cl A (VERA)
Astrazeneca Sponsored Adr (AZN)
Disc Medicine (IRON)
89bio (ETNB)
Apogee Therapeutics (APGE)
Travere Therapeutics (TVTX)
Tenet Healthcare Corp Com New (THC)

View all positions for Exome Asset Management

Top funds holding Neumora Therapeutics

Group One Trading
Simplex Trading

View all funds holding Neumora Therapeutics